Skip to main content
Pangen Biotech Inc. logo

Pangen Biotech Inc. — Investor Relations & Filings

Ticker · 222110 ISIN · KR7222110009 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2023-09-27 AGM Information
Country KR South Korea
Listing KO 222110

About Pangen Biotech Inc.

https://pangen.com/layout/eng/home.php

Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing from a Korean company (Pangen) regarding a change in the date of an Extraordinary General Meeting (EGM). It is a 'Correction Report' (정정신고) for a 'Resolution to Convene a General Meeting of Shareholders' (주주총회소집결의). Since this document provides notice of a meeting and its agenda, but is not the full proxy statement or the presentation materials themselves, it falls under the category of general regulatory announcements regarding corporate governance events.
2023-09-27 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory announcement regarding the adjustment of the conversion price for convertible bonds (전환가액의 조정). It details the change in conversion price, the number of convertible shares, the reason for the adjustment (market price decline), and the calculation methodology. This type of filing relates to capital structure changes and financing instruments, which falls under the 'Capital/Financing Update' category.
2023-09-20 Korean
투자판단관련주요경영사항(빈혈치료제인 팬포틴프리필드시린지주 6000IU 및 10000IU 품목허가 획득))
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'major management matter' (투자판단 관련 주요경영사항). It announces that the company, Pangen, has received product approval from the Ministry of Food and Drug Safety for its anemia treatment. Since this is a specific regulatory disclosure of a material event that does not fit into categories like financial reports, dividends, or M&A, it is classified as a general regulatory filing.
2023-08-25 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder register closure to facilitate an Extraordinary General Meeting. It does not contain the full proxy materials or the meeting results themselves, but rather serves as a formal regulatory notice of an upcoming corporate event. Given the nature of the announcement, it falls under the general regulatory filing category.
2023-08-21 Korean
주주총회소집결의(임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company Pangen, detailing the date, time, location, and agenda items (specifically the appointment of directors). This type of document is a standard proxy solicitation or meeting notice sent to shareholders to inform them of an upcoming meeting and the matters to be voted upon. Given the provided categories, 'PSI' (Proxy Solicitation & Information Statement) is the most accurate classification for a notice of a shareholder meeting.
2023-08-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details a change in share ownership by a major shareholder (Huons Co., Ltd.) in the issuing company (PanGen). This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) in our taxonomy, as it reports insider/major shareholder transactions.
2023-08-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.